PRINCETON, N.J., Aug. 19, 2022 /PRNewswire/ — Calyptus Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) granted approval to an Abbreviated New Drug Application (ANDA) for an AP-rated generic version of Cetrotide® (Cetrorelix Acetate for Injection, 0.25…

Generated by Feedzy